To determine if any differences in lymphocyte gene expression between the HPV(+) and HPV(−) tumor cohorts were retained following TIL correction, the DEGs identified after correction were overlapped with the lymphocyte-specific marker genes used to determine the cell proportions in the FAIME analysis (CD19+ B-cell genes and CD8+ and CD4+ T-cell genes, Supplementary Table S6 [21–26]). The gene discussed is CD19; the disease is neoplasm.